516 related articles for article (PubMed ID: 26307268)
1. Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC).
Thomas C; Spanidis M; Engel C; Roos FC; Frees S; Neisius A; Hampel C; Rubenwolf P; Thüroff JW; Walter C; Miederer M
Clin Oral Investig; 2016 May; 20(4):753-8. PubMed ID: 26307268
[TBL] [Abstract][Full Text] [Related]
2. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
[TBL] [Abstract][Full Text] [Related]
3. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate-related osteonecrosis of the jaws.
Kushner GM; Alpert B
Curr Opin Otolaryngol Head Neck Surg; 2011 Aug; 19(4):302-6. PubMed ID: 21677585
[TBL] [Abstract][Full Text] [Related]
5. Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid - A prospective study over 6 years.
Mücke T; Deppe H; Hein J; Wolff KD; Mitchell DA; Kesting MR; Retz M; Gschwend JE; Thalgott M
J Craniomaxillofac Surg; 2016 Oct; 44(10):1689-1693. PubMed ID: 27555374
[TBL] [Abstract][Full Text] [Related]
6. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
7. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
8. Does regular zoledronic acid change the bone turnover of the jaw in men with metastatic prostate cancer: a possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw?
Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Ristow M; Koerdt S; Schuster R; Otto S; Pautke C
J Cancer Res Clin Oncol; 2014 Mar; 140(3):487-93. PubMed ID: 24469255
[TBL] [Abstract][Full Text] [Related]
9. Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis?
Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Otto S; Pautke C
J Oral Maxillofac Surg; 2014 May; 72(5):903-10. PubMed ID: 24485975
[TBL] [Abstract][Full Text] [Related]
10. Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw.
Wilde F; Steinhoff K; Frerich B; Schulz T; Winter K; Hemprich A; Sabri O; Kluge R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Mar; 107(3):412-9. PubMed ID: 19121962
[TBL] [Abstract][Full Text] [Related]
11. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review.
Fliefel R; Tröltzsch M; Kühnisch J; Ehrenfeld M; Otto S
Int J Oral Maxillofac Surg; 2015 May; 44(5):568-85. PubMed ID: 25726090
[TBL] [Abstract][Full Text] [Related]
12. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
Assael LA
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
[TBL] [Abstract][Full Text] [Related]
13. Persistent bone resorption lacunae on necrotic bone distinguish bisphosphonate-related osteonecrosis of jaw from denosumab-related osteonecrosis.
Aoki K; Matsunaga S; Ito S; Shibahara T; Nomura T; Matsuzaki H; Abe S; Yamaguchi A
J Bone Miner Metab; 2021 Sep; 39(5):737-747. PubMed ID: 33830351
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate-related osteonecrosis of the jaw: what we have learned.
Tabari E; Sikavi C
Alpha Omegan; 2014; 107(2):8-15. PubMed ID: 25269218
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.
Koth VS; Figueiredo MA; Salum FG; Cherubini K
Dentomaxillofac Radiol; 2016; 45(7):20160049. PubMed ID: 27167455
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice.
Kuroshima S; Sasaki M; Nakajima K; Tamaki S; Hayano H; Sawase T
Bone; 2018 Jul; 112():177-186. PubMed ID: 29729428
[TBL] [Abstract][Full Text] [Related]
17. Intraindividual comparison of preoperative (99m)Tc-MDP SPECT/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw.
Assaf AT; Zrnc TA; Remus CC; Adam G; Zustin J; Heiland M; Friedrich RE; Derlin T
J Craniomaxillofac Surg; 2015 Oct; 43(8):1461-9. PubMed ID: 26232916
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?
Lescaille G; Coudert AE; Baaroun V; Javelot MJ; Cohen-Solal M; Berdal A; Goudot P; Azérad J; Ruhin B; Descroix V
J Rheumatol; 2013 Jun; 40(6):781-6. PubMed ID: 23504384
[TBL] [Abstract][Full Text] [Related]
19. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.
Dodson TB
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814
[TBL] [Abstract][Full Text] [Related]
20. [Risk assessment of bisphosphonate-related osteonecrosis of the jaw based on CBCT scans].
Koppány F; Joób-Fancsaly Á; Németh Z; Belik AA; Vaszilkó M; Varmuzsa EM; Csomó KB
Orv Hetil; 2020 May; 161(21):867-872. PubMed ID: 32427571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]